Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Enact HoldingsACT +1.72%73 3-Year EPS without NRI Growth Rate is 2.00% as of Mar. 2026, which is 69% below its 10-year median of 6.35. GuruFocus rates ACT with a GF Score™ of 73/100 and a GF Value™ of $38.58 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 401 Insurance companies, Enact Holdings ranks worse than 75.06% on this metric.
During the past 12 months, Enact Holdings's average EPS without NRI Growth Rate was 0.90% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 2.00% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 13.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 7 years, the highest 3-Year average EPS without NRI Growth Rate of Enact Holdings was 22.50% per year. The lowest was 1.40% per year. And the median was 6.35% per year.
Enact Holdings (NAS:ACT) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Enact Holdings 3-Year EPS without NRI Growth Rate Related Terms
ACT vs ESNT, MTG, FAF: 3-Year EPS without NRI Growth Rate Comparison
For the Insurance - Specialty subindustry, Enact Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enact Holdings 3-Year EPS without NRI Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Enact Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Enact Holdings's 3-Year EPS without NRI Growth Rate falls into.
Enact Holdings 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 2.00% mean?
Enact Holdings (ACT) has a 3-Year EPS without NRI Growth Rate of 2.00% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Enact Holdings and its competitors. This is 69% below median its historical median of 6.35. Over the past decade, Enact Holdings' 3-Year EPS without NRI Growth Rate has ranged from 1.40 to 22.50. According to the industry distribution chart, Enact Holdings ranks #301 out of 401 companies in the Insurance industry, placing it in the top 75.1%.
Is Enact Holdings' 3-Year EPS without NRI Growth Rate too high?
Enact Holdings' current 3-Year EPS without NRI Growth Rate of 2.00% is 69% below median its 10-year median of 6.35. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 22.50. The Insurance industry median 3-Year EPS without NRI Growth Rate is 16.50. Enact Holdings' value of 2.00% is 87.9% below this industry median. Based on the distribution chart, Enact Holdings ranks #301 out of 401 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Enact Holdings has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Enact Holdings' 3-Year EPS without NRI Growth Rate compare to ESNT and MTG?
According to the Insurance industry distribution chart, Enact Holdings ranks #301 out of 401 companies for 3-Year EPS without NRI Growth Rate. This places Enact Holdings in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 16.50. Enact Holdings' value of 2.00% is 87.9% below this benchmark. Historically, Enact Holdings' own 3-Year EPS without NRI Growth Rate has ranged from 1.40 to 22.50 over the past decade. While the company's 10-year median is 6.35 vs. the industry median of 16.50, Enact Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for an Insurance company?
The median 3-Year EPS without NRI Growth Rate among Insurance companies is 16.50, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Enact Holdings's current 3-Year EPS without NRI Growth Rate of 2.00% is 87.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Enact Holdings and its competitors. For the Insurance industry, the median 3-Year EPS without NRI Growth Rate is 16.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enact Holdings's current 3-Year EPS without NRI Growth Rate is 2.00%, which is 69% below median its own 10-year median of 6.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enact Holdings stock overvalued right now?
Based on GuruFocus' analysis, Enact Holdings (ACT) is currently considered Modestly Overvalued. The stock's GF Value™ is $38.58, compared to a current price of $46.76 — trading 21.2% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 2.00%, which is 69% below median its 10-year median of 6.35 and 87.9% below the Insurance industry median of 16.50. Enact Holdings' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Enact Holdings (ACT), the current 3-Year EPS without NRI Growth Rate is 2.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Enact Holdings (ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Enact Holdings stock appears to be overvalued.
The current stock price of $46.76 is trading 21.2% above its estimated GF Value™ of $38.58.
GuruFocus considers Enact Holdings to be Modestly Overvalued.
Key valuation signals for ACT:
3-Year EPS without NRI Growth Rate: 2.00% (69% below median its 10-year median of 6.35)
GF Value™: $38.58 vs. price of $46.76 (21.2% above fair value)
Industry Position: 87.9% below the Insurance median (#301 of 401)
No single metric tells the full story. See the ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
73GF Score
Get the complete analysis for ACT
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACT has been successfully added to your 
